UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Umbilical cord blood: The promise and the uncertainty

Stem cells translational medicine, 2020-10, Vol.9 (10), p.1153-1162

2020

Link zum Volltext

Verfügbarkeit prüfen

Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1125-1134

2017

Link zum Volltext

Verfügbarkeit prüfen

Is anemia a harbinger of poorer outcomes after allogeneic hematopoietic cell transplant?

Bone marrow transplantation (Basingstoke), 2020-02, Vol.55 (2), p.275-277

2020

Link zum Volltext

Verfügbarkeit prüfen

Results of a prospective multicentre myeloablative double‐unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia

British journal of haematology, 2015-02, Vol.168 (3), p.405-412

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients

Clinical lymphoma, myeloma and leukemia, 2015-07, Vol.15 (7), p.428-432.e2

2015

Link zum Volltext

Verfügbarkeit prüfen

Minimal Change Disease Secondary to Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome

Case reports in nephrology and dialysis, 2022-01, Vol.12 (1), p.31-37

2022

Link zum Volltext

Verfügbarkeit prüfen

How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?

Blood reviews, 2023-07, Vol.60, p.101079-101079, Article 101079

2023

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of metastatic pancreatoblastoma in an adult with autologous hematopoietic cell transplant

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2021-01, Vol.21 (1), p.188-191

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults

British journal of haematology, 2007-11, Vol.139 (3), p.464-474

2007

Link zum Volltext

Verfügbarkeit prüfen

Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC, EQ-5D and MY-20 scales

Leukemia & lymphoma, 2019-04, Vol.60 (5), p.1275-1282

2019

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic pretransplant ganciclovir to reduce cytomegalovirus infection after hematopoietic stem cell transplantation

Hematology/oncology and stem cell therapy, 2023-01

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.335-341

2015

Link zum Volltext

Verfügbarkeit prüfen

Role of the proteasome in modulating native G-CSFR expression

Cytokine (Philadelphia, Pa.), 2008-08, Vol.43 (2), p.114-123

2008

Link zum Volltext

Verfügbarkeit prüfen

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Journal of clinical oncology, 2016-06, Vol.34 (16), p.1864-1871

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospective Observational Study Evaluating Risk Factors for Plasma Cell (PC) Contamination of Cellular Products in Multiple Myeloma (MM) Patients (Pts) Mobilized with G-CSF (G)/Plerixafor (P)

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S134-S135

2017

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Maintenance Therapy in the Treatment of Multiple Myeloma with a Subset Analysis on Patients Who Achieve a Complete Response (CR) or Better: A Retrospective Analysis

Blood, 2017-12, Vol.130, p.4548-4548

2017

Link zum Volltext

Verfügbarkeit prüfen

Absolute Lymphocyte Count (ALC) Recovery in Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplant (ASCT) Is Related to CD34+ Dose-Infused

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S135-S135

2015

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Safety and Efficacy Data Using CDX-301 (Flt3 ligand) As a Sole Agent to Mobilize Hematopoietic Cells Prior to HLA-Matched Sibling Donor Transplantation

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S324-S325

2016

Link zum Volltext

Verfügbarkeit prüfen

Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients

Blood, 2018-11, Vol.132 (Supplement 1), p.3435-3435

2018

Link zum Volltext

Verfügbarkeit prüfen

A Step Forward Towards Cytomegalovirus Free Hematopoietic Stem Cell Transplantation

Blood, 2018-11, Vol.132 (Supplement 1), p.5708-5708

2018

Link zum Volltext

Verfügbarkeit prüfen

Plasma Cells in the Cellular Product Impact Progression Free Survival (PFS) but Not Overall Survival (OS) after Autologous (Auto) Hematopoietic Cell Transplant (HCT)

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S410-S411

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(71)
Berichte
(1)

Sprache

Englisch
(72)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(21)
Hematology, Oncology And Palliative Medicine
(20)
Hematology
(17)
Middle Aged
(15)
Adult
(14)
Female
(13)
Male
(13)
Transplantation
(13)
Aged
(12)
Oncology
(11)
Hematopoietic Stem Cell Transplantation
(10)
Medicin Och Hälsovetenskap
(9)
Immunology
(8)
Transplantation, Homologous
(7)
Adolescent
(6)
Cancer Research
(5)
Retrospective Studies
(5)
Treatment Outcome
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Umbilical cord blood: The promise and the uncertainty

Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high‐risk myelodysplastic syndromes: Challenges and opportunities in implementation

Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America

Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017

Is anemia a harbinger of poorer outcomes after allogeneic hematopoietic cell transplant?

Results of a prospective multicentre myeloablative double‐unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia

A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients

Minimal Change Disease Secondary to Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program

How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?

Successful treatment of metastatic pancreatoblastoma in an adult with autologous hematopoietic cell transplant

Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults

Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC, EQ-5D and MY-20 scales

Prophylactic pretransplant ganciclovir to reduce cytomegalovirus infection after hematopoietic stem cell transplantation

Impact of Pretransplant Therapy and Depth of Disease Response before Autologous Transplantation for Multiple Myeloma

Role of the proteasome in modulating native G-CSFR expression

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome

Prospective Observational Study Evaluating Risk Factors for Plasma Cell (PC) Contamination of Cellular Products in Multiple Myeloma (MM) Patients (Pts) Mobilized with G-CSF (G)/Plerixafor (P)

The Impact of Maintenance Therapy in the Treatment of Multiple Myeloma with a Subset Analysis on Patients Who Achieve a Complete Response (CR) or Better: A Retrospective Analysis

Absolute Lymphocyte Count (ALC) Recovery in Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplant (ASCT) Is Related to CD34+ Dose-Infused

Preliminary Safety and Efficacy Data Using CDX-301 (Flt3 ligand) As a Sole Agent to Mobilize Hematopoietic Cells Prior to HLA-Matched Sibling Donor Transplantation

Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients

A Step Forward Towards Cytomegalovirus Free Hematopoietic Stem Cell Transplantation

Plasma Cells in the Cellular Product Impact Progression Free Survival (PFS) but Not Overall Survival (OS) after Autologous (Auto) Hematopoietic Cell Transplant (HCT)

Suchergebnisse filtern